Substandard

Pharmaceutical Manufacturing in LMICs: Where Things Go Wrong

Root Causes of Substandard Medicines

In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.

Share

A Multi-Sectorial Approach to Ensuring Medical Product Quality & Supply Chain Integrity

USP Contributes to APEC Initiative to Ensure Medical Product Quality & Supply Chain Integrity

Learn about USP's involvement in the APEC Life Sciences Innovation Forum and how this group is improving access to quality medical products by helping Asian-Pacific economies prevent, detect and respond to spurious, substandard, falsified, falsely-labelled and counterfeit products in their supply chains.

Share

Removing Barriers to Improve Drug Quality in Africa

USP's Patrick Lukulay explains work to improve drug quality in Africa

Patrick Lukulay, USP’s VP of GHIPAfrica, discusses plans to leverage his new post in Accra, Ghana to advance pharmaceutical quality in Africa. Countering fallacies in drug quality through advocacy and working to help build an enabling environment that can sustain systems for effective regulation of medical products, he says, are needed for this to happen.

Share

Pages